세포 분석 시장 : 2027년까지의 세계 예측

출판 : MarketsandMarkets(마켓츠앤드마켓츠)출판년월 : 2022년05월

세포 분석 시장 : 제품 및 서비스(시약 및 소모품, 장비), 기술(유동 세포 계측, 고용량 스크리닝), 프로세스(단일 세포 분석), 최종 사용자(제약, 생명공학 기업) – 2027년까지의 세계 예측

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) – Global Forecast to 2027

페이지수 228
도표수 274
구성 영문조사보고서
가격

리포트목차    주문/문의    납기/라이센스안내

Sample Request

The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand,high costs associated with cell analysis instruments along with limitations on the usage of reagents for experiments is expected to restrain the market growth.
세계 세포 분석 시장은 예측 기간 동안 10.1%의 CAGR로 2022년 177억 달러에서 2027년 286억 달러에 이를 것으로 예상됩니다. 세포 분석 시장의 주요 기회에는 신흥 경제, 전염병 및 전염병 발병의 높은 위험, 다양한 암 연구 응용 분야에서 새로운 세포 분석의 채택 증가 등이 있습니다. 한편, 세포 분석 장비와 관련된 높은 비용과 실험용 시약 사용의 제한이 시장 성장을 억제할 것으로 예상됩니다.

“The reagents & consumables segment dominates the cell analysis market through the study period of 2020-2027.”

Based on product & service, the global cell analysis market is segmented into reagents & consumables, instruments, accessories, software, and services. The reagents & consumables segment represented largest market share for the year 2021, in cell analysis market. Development of affordable reagent solutions by key market players is the key attributive factor to the segment’s dominance. This is further supplemented by increasing demand for novel cell analysis reagents & consumables in flow cytometry experiments.

“The high content screening (HCS) segment will witness the highest growth in the cell analysis market during the forecast period.”

Based on technique, the global cell analysis market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening (HCS), and other techniques. HCS techniquecombineshigh-throughput automated imaging with analysis which helps inthe extraction of single-cell data, multi-parametric in nature. In addition, widening applications of HCS have contributed to the robust CAGR registered by this segment from 2022-2027.

“North America dominated the cell analysis market in 2021.”
Geographically, the cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share of the cell analysis market. North America harbors majority of the key market players leading to maturity of cell analysis market in this region. Also, robust government support for academic & research activities offer opportunity for the key market players to introduce cutting-edge cell analysis products, further intensifying regional market competition.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type -Tier 1: 37%, Tier 2: 23%,and Tier 3: 40%
• By Designation – C-level:32%, D-level:26%, and Others:42%
• By Region – North America:35%, Europe:25%, Asia Pacific:20%, Latin America: 12%, and the Middle East and Africa: 8%
List of Companies Profiled in the Report
• Danaher (US)
• Thermo Fisher Scientific (US)
• BectonDickinson and Company (US)
• General Electric (US)
• Merck KGaA (US)
• Agilent Technologies (US)
• Olympus Corporation (Japan)
• MiltenyiBiotec (US)
• Bio-Rad Laboratories (US)
• BioStatus Limited (UK)
• Fluidigm Corporation (US)
• NanoCellect Biomedical (US)
• Cell Biolabs (US)
• Creative Bioarray (US)
• Meiji Techno (US)
• Promega Corporation (US)
• PerkinElmer (US)
• Tecan Trading AG (Switzerland)
• CELLINK (US)
• QIAGEN (Germany)
• Corning Incorporated (US)
• 10x Genomics (US)
• Illumina (US)

Research Coverage:
This report provides a detailed picture of the global cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product& service,technique, process, end user,and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell analysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell analysis offered by the top 25 players in the cell analysis market. The report analyses the cell analysis market by product& service,technique, process, end user, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell analysis across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell analysis market.

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the cell analysis market.


목차

TABLE OF CONTENTS

1 INTRODUCTION (Page No. – 32)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. – 36)
    2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 CELL ANALYSIS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE)
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION (2021)
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST
FIGURE 6 CELL ANALYSIS MARKET: CAGR PROJECTIONS (2022–2027)
FIGURE 7 CELL ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 INSIGHTS FROM PRIMARIES
FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS
2.6 RESEARCH ASSUMPTIONS
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS
2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. – 47)
FIGURE 10 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 CELL ANALYSIS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 12 CELL ANALYSIS MARKET, BY PROCESS, 2022 VS. 2027 (USD MILLION)
FIGURE 13 CELL ANALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE CELL ANALYSIS MARKET

4 PREMIUM INSIGHTS (Page No. – 52)
4.1 CELL ANALYSIS MARKET OVERVIEW
FIGURE 15 INCREASING FUNDING FOR CELL-BASED RESEARCH TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: CELL ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2021)
FIGURE 16 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021
4.3 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 17 FLOW CYTOMETRY SEGMENT WILL CONTINUE TO DOMINATE NORTH AMERICAN MARKET IN 2027

5 MARKET OVERVIEW (Page No. – 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
TABLE 1 CELL ANALYSIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising preference for cell-based assays in drug discovery
5.2.1.2 Increasing funding for cell-based research
5.2.1.3 Growing number of drug discovery activities
5.2.2 RESTRAINT
5.2.2.1 High cost of instruments and restrictions on reagent use
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Growing risk of pandemics and communicable diseases
5.2.3.3 Application of novel cell-based assays in cancer research
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF BUYERS
5.3.4 BARGAINING POWER OF SUPPLIERS
5.3.5 DEGREE OF COMPETITION
5.4 IMPACT OF COVID-19 ON THE CELL ANALYSIS MARKET
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 19 CELL ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS (CELL-BASED ASSAYS)
5.6 VALUE CHAIN ANALYSIS
FIGURE 20 CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
FIGURE 21 CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS
5.8 REGULATORY ANALYSIS (FLOW CYTOMETRY-BASED CELL ANALYSIS)
5.8.1 STRINGENT FDA REQUIREMENTS
5.8.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE
5.8.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS
5.8.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS
5.8.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS
5.8.6 US REIMBURSEMENT SCENARIO
5.9 TECHNOLOGY ANALYSIS
FIGURE 22 TECHNOLOGY ANALYSIS: CELL ANALYSIS MARKET
5.10 KEY CONFERENCES & EVENTS, 2021–2022
5.10.1 CELL ANALYSIS CONFERENCES, 2022
TABLE 3 CELL ANALYSIS CONFERENCES (2022)
5.10.2 CELL ANALYSIS CONFERENCES, 2021
TABLE 4 CELL ANALYSIS CONFERENCES (2021)
5.11 PRICING ANALYSIS
5.11.1 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES
TABLE 5 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES (TOP 5)
FALSE
5.11.2 AVERAGE SELLING PRICE TREND

6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE (Page No. – 70)
    6.1 INTRODUCTION
TABLE 6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
6.2 REAGENTS & CONSUMABLES
6.2.1 ADVENT OF NOVEL CELL ANALYSIS KITS & REAGENTS FOR FLOW CYTOMETRY TO BOOST SEGMENT GROWTH
TABLE 7 CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 8 NORTH AMERICA: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 9 EUROPE: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 10 ASIA PACIFIC: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
6.3.1 INNOVATIONS IN CELL ANALYSIS INSTRUMENTS FOR DRUG DISCOVERY RESEARCH TO DRIVE MARKET GROWTH
TABLE 11 CELL ANALYSIS INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 12 NORTH AMERICA: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 13 EUROPE: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 ASIA PACIFIC: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 ACCESSORIES
6.4.1 FLOW CYTOMETRY ACCESSORIES ENABLE END USERS TO CUSTOMIZE FLOW CYTOMETRY INSTRUMENTS
TABLE 15 CELL ANALYSIS ACCESSORIES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 16 NORTH AMERICA: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 17 EUROPE: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 18 ASIA PACIFIC: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.5 SOFTWARE
6.5.1 EXPANDING POOL OF KEY PLAYERS INTRODUCING UNIQUE SOFTWARE OR DATA INTERPRETATION TOOLS PROPELS SEGMENT GROWTH
TABLE 19 CELL ANALYSIS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 20 NORTH AMERICA: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 21 EUROPE: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 22 ASIA PACIFIC: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.6 SERVICES
6.6.1 REMOTE SERVICES ENSURE WORKFLOW CONTINUITY AND MAXIMIZE PERFORMANCE
TABLE 23 CELL ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 24 NORTH AMERICA: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 25 EUROPE: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 26 ASIA PACIFIC: CELL ANALYSIS SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

7 CELL ANALYSIS MARKET, BY TECHNIQUE (Page No. – 82)
7.1 INTRODUCTION
TABLE 27 CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
7.2 FLOW CYTOMETRY
7.2.1 ABILITY TO PERFORM MULTIPLE MEASUREMENTS ON SINGLE CELLS IS KEY ADVANTAGE ASSOCIATED WITH THIS TECHNIQUE
TABLE 28 CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION, 2020–2027 (USD MILLION)
TABLE 29 NORTH AMERICA: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 30 EUROPE: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 31 ASIA PACIFIC: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 PCR
7.3.1 DIGITAL PCR CAN EFFECTIVELY MEASURE AND MONITOR RARE SEQUENCES
TABLE 32 CELL ANALYSIS MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
TABLE 33 NORTH AMERICA: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 34 EUROPE: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 CELL MICROARRAYS
7.4.1 CELL MICROARRAYS ARE USED IN DESIGNING AND CONTROLLING STEM CELLS IN TISSUE ENGINEERING
TABLE 36 CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY REGION, 2020–2027 (USD MILLION)
TABLE 37 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 38 EUROPE: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 39 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 MICROSCOPY
7.5.1 RISING INCIDENCE OF CANCER AND GROWING INVESTMENTS IN CELL BIOLOGY TO DRIVE MARKET GROWTH
TABLE 40 CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION, 2020–2027 (USD MILLION)
TABLE 41 NORTH AMERICA: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 EUROPE: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 ASIA PACIFIC: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION)
7.6 SPECTROPHOTOMETRY
7.6.1 HIGH DEMAND FOR SPECTROPHOTOMETERS IN RESEARCH SETTINGS TO SUPPORT MARKET GROWTH
TABLE 44 CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY REGION, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 EUROPE: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 47 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION)
7.7 HIGH-CONTENT SCREENING (HCS)
7.7.1 HIGH DEMAND FOR HCS IN CELL BEHAVIOR RESEARCH STUDIES TO SUPPORT SEGMENT GROWTH
TABLE 48 CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 EUROPE: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020–2027 (USD MILLION)
7.8 OTHER TECHNIQUES
TABLE 52 CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION, 2020–2027 (USD MILLION)
TABLE 53 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 54 EUROPE: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 55 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION)

8 CELL ANALYSIS MARKET, BY PROCESS (Page No. – 98)
    8.1 INTRODUCTION
TABLE 56 CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
8.2 CELL IDENTIFICATION
8.2.1 INCREASING RESEARCH ACTIVITIES TO PROPEL MARKET GROWTH
TABLE 57 CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY REGION, 2020–2027 (USD MILLION)
TABLE 58 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 59 EUROPE: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 60 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 CELL VIABILITY
8.3.1 CELL VIABILITY IS USED TO CORRELATE CELL BEHAVIOR TO CELL NUMBERS
TABLE 61 CELL ANALYSIS MARKET FOR CELL VIABILITY, BY REGION, 2020–2027 (USD MILLION)
TABLE 62 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 63 EUROPE: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 64 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION
8.4.1 HIGH DEMAND FOR TOXICITY TESTING IN DRUG DEVELOPMENT TO DRIVE MARKET GROWTH
TABLE 65 CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY REGION, 2020–2027 (USD MILLION)
TABLE 66 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 67 EUROPE: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020–2027 (USD MILLION)
8.5 CELL PROLIFERATION
8.5.1 CELL PROLIFERATION IS MEASURED ON THE BASIS OF AVERAGE DNA CONTENT
TABLE 69 CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY REGION, 2020–2027 (USD MILLION)
TABLE 70 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 71 EUROPE: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 72 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020–2027 (USD MILLION)
8.6 CELL COUNTING & QUALITY CONTROL
8.6.1 FLOW CYTOMETRY ENABLES EASY DIFFERENTIATION OF CELLS VIA SCATTERING OR STAINING
TABLE 73 CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY REGION, 2020–2027 (USD MILLION)
TABLE 74 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 75 EUROPE: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 76 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION)
8.7 CELL INTERACTION
8.7.1 INCREASING ADVANCEMENTS IN CELL-CELL INTERACTIONS/CELL-CELL COMMUNICATION TO BOOST MARKET GROWTH
TABLE 77 CELL ANALYSIS MARKET FOR CELL INTERACTION, BY REGION, 2020–2027 (USD MILLION)
TABLE 78 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 79 EUROPE: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 80 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020–2027 (USD MILLION)
8.8 CELL STRUCTURE STUDY
8.8.1 ADVANCEMENTS IN CELLULAR IMAGING TO SUPPORT MARKET GROWTH
TABLE 81 CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY REGION, 2020–2027 (USD MILLION)
TABLE 82 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 83 EUROPE: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 84 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY COUNTRY, 2020–2027 (USD MILLION)
8.9 TARGET IDENTIFICATION & VALIDATION
8.9.1 HCS IN TARGET IDENTIFICATION IS USED TO IDENTIFY NOVEL TARGETS THROUGH SCREENING OF CELLULAR PATHWAYS
TABLE 85 CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY REGION, 2020–2027 (USD MILLION)
TABLE 86 NORTH AMERICA: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 87 EUROPE: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION)
8.10 SINGLE-CELL ANALYSIS
8.10.1 EXPANDING APPLICATIONS OF SINGLE-CELL ANALYSIS IN CLINICAL RESEARCH TO PROPEL SEGMENT GROWTH
TABLE 89 CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY REGION, 2020–2027 (USD MILLION)
TABLE 90 NORTH AMERICA: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 91 EUROPE: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 92 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION)

9 CELL ANALYSIS MARKET, BY END USER (Page No. – 121)
9.1 INTRODUCTION
TABLE 93 CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.2.1 HIGH DEMAND FOR CELL-BASED RESEARCH IN DRUG DISCOVERY & DEVELOPMENT PROCESS CONTRIBUTES TO SEGMENT GROWTH
TABLE 94 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 95 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 96 NORTH AMERICA: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 97 EUROPE: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 98 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES
9.3.1 DEVELOPMENT OF COMPLEX & HIGHLY SPECIALIZED TESTS AND ASSAYS SUPPORTS MARKET GROWTH
TABLE 99 CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 100 NORTH AMERICA: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 101 EUROPE: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 102 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.4 ACADEMIC & RESEARCH INSTITUTES
9.4.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH
TABLE 103 CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION)
TABLE 104 NORTH AMERICA: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 105 EUROPE: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 106 ASIA PACIFIC: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION)
9.5 OTHER END USERS
TABLE 107 CELL ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 108 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 109 EUROPE: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 110 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)

10 CELL ANALYSIS MARKET, BY REGION (Page No. – 133)
     10.1 INTRODUCTION
TABLE 111 CELL ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: CELL ANALYSIS MARKET SNAPSHOT
TABLE 112 NORTH AMERICA: CELL ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 113 NORTH AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 114 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 115 NORTH AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 116 NORTH AMERICA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 US dominates North American cell analysis market
TABLE 117 US: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 118 US: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 119 US: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 120 US: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing government initiatives targeted toward stem cell research to drive market growth
TABLE 121 CANADA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 122 CANADA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 123 CANADA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 124 CANADA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 125 EUROPE: CELL ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 126 EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 127 EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 128 EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 129 EUROPE: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Strong R&D infrastructure, training, and awareness programs ensure market growth in Germany
TABLE 130 GERMANY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 131 GERMANY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 132 GERMANY: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 133 GERMANY: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Presence of large biotechnology industry favors market growth
TABLE 134 FRANCE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 135 FRANCE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 136 FRANCE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 137 FRANCE: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Growing acceptance of flow cytometry products for clinical diagnostics to drive market growth
TABLE 138 UK: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 139 UK: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 140 UK: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 141 UK: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Increasing research activities and conferences to support market growth
TABLE 142 ITALY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 143 ITALY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 144 ITALY: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 145 ITALY: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Growing focus on cancer diagnosis increased flow cytometry product usage in Spain
TABLE 146 SPAIN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 147 SPAIN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 148 SPAIN: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 149 SPAIN: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 150 REST OF EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 151 REST OF EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 152 REST OF EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 153 REST OF EUROPE: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: CELL ANALYSIS MARKET SNAPSHOT
TABLE 154 ASIA PACIFIC: CELL ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 155 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 156 ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 157 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 158 ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 JAPAN
10.4.1.1 Easy access to technologically advanced cell analysis products to favor market growth
TABLE 159 JAPAN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 160 JAPAN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 161 JAPAN: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 162 JAPAN: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 CHINA
10.4.2.1 Developments in biotechnology sector to support market growth
TABLE 163 CHINA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 164 CHINA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 165 CHINA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 166 CHINA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Government initiatives to drive market growth in India
TABLE 167 INDIA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 168 INDIA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 169 INDIA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 170 INDIA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 171 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH
TABLE 175 LATIN AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 176 LATIN AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 177 LATIN AMERICA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 178 LATIN AMERICA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING RESEARCH ACTIVITIES WILL FUEL DEMAND FOR CELL ANALYSIS PRODUCTS
TABLE 179 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. – 177)
11.1 INTRODUCTION
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
FIGURE 25 CELL ANALYSIS MARKET: STRATEGIES ADOPTED
11.3 MARKET SHARE ANALYSIS
FIGURE 26 CELL ANALYSIS MARKET SHARE ANALYSIS (2021)
11.4 REVENUE SHARE ANALYSIS (TOP 7 MARKET PLAYERS)
FIGURE 27 REVENUE ANALYSIS FOR KEY COMPANIES, 2018–2021
11.5 COMPANY EVALUATION QUADRANT
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 28 CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, 2021
11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/ SMES/START-UPS (2021)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
FIGURE 29 CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021
11.7 COMPETITIVE SCENARIO AND TRENDS
11.7.1 PRODUCT LAUNCHES
TABLE 183 CELL ANALYSIS MARKET: PRODUCT LAUNCHES
11.7.2 DEALS
TABLE 184 CELL ANALYSIS MARKET: DEALS
11.7.3 OTHER DEVELOPMENTS
TABLE 185 CELL ANALYSIS MARKET: OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. – 187)
12.1 KEY COMPANIES
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1.1 THERMO FISHER SCIENTIFIC INC.
TABLE 186 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)
TABLE 187 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS
TABLE 188 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCH
TABLE 189 THERMO FISHER SCIENTIFIC INC.: DEALS
12.1.2 DANAHER
TABLE 190 DANAHER: BUSINESS OVERVIEW
FIGURE 31 DANAHER: COMPANY SNAPSHOT (2021)
TABLE 191 DANAHER: PRODUCT OFFERINGS
TABLE 192 DANAHER: DEALS
TABLE 193 DANAHER: OTHER DEVELOPMENTS
12.1.3 BECTON, DICKINSON AND COMPANY (BD)
TABLE 194 BD: BUSINESS OVERVIEW
FIGURE 32 BD: COMPANY SNAPSHOT (2021)
TABLE 195 BD: PRODUCT OFFERINGS
TABLE 196 BD: PRODUCT LAUNCH
12.1.4 GENERAL ELECTRIC
TABLE 197 GE: BUSINESS OVERVIEW
FIGURE 33 GE: COMPANY SNAPSHOT (2021)
TABLE 198 GE: PRODUCT OFFERINGS
TABLE 199 GE HEALTHCARE: OTHER DEVELOPMENTS
12.1.5 MERCK KGAA
TABLE 200 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2021)
TABLE 201 MERCK KGAA: PRODUCT OFFERINGS
TABLE 202 MERCK KGAA: DEALS
12.1.6 AGILENT TECHNOLOGIES, INC.
TABLE 203 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 35 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021)
TABLE 204 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS
TABLE 205 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
12.1.7 BIO-RAD LABORATORIES, INC.
TABLE 206 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021)
TABLE 207 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS
TABLE 208 BIO-RAD LABORATORIES, INC.: DEALS
12.1.8 FLUIDIGM CORPORATION
TABLE 209 FLUIDIGM CORPORATION: BUSINESS OVERVIEW
FIGURE 37 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2021)
TABLE 210 FLUIDIGM CORPORATION: PRODUCT OFFERINGS
TABLE 211 FLUIDIGM CORPORATION: DEALS
12.1.9 MILTENYI BIOTEC
TABLE 212 MILTENYI BIOTEC: BUSINESS OVERVIEW
TABLE 213 MILTENYI BIOTEC: PRODUCT OFFERINGS
TABLE 214 MILTENYI BIOTEC: PRODUCT LAUNCHES
12.1.10 OLYMPUS CORPORATION
TABLE 215 OLYMPUS CORPORATION: BUSINESS OVERVIEW
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021)
TABLE 216 OLYMPUS CORPORATION: PRODUCT OFFERINGS
12.1.11 BIOSTATUS LIMITED
TABLE 217 BIOSTATUS LIMITED: BUSINESS OVERVIEW
TABLE 218 BIOSTATUS LIMITED: PRODUCT OFFERINGS
12.1.12 NANOCELLECT BIOMEDICAL
TABLE 219 NANOCELLECT BIOMEDICAL: BUSINESS OVERVIEW
TABLE 220 NANOCELLECT BIOMEDICAL: PRODUCT OFFERINGS
TABLE 221 NANOCELLECT BIOMEDICAL: DEALS
TABLE 222 NANOCELLECT BIOMEDICAL: PRODUCT LAUNCH
12.1.13 CELL BIOLABS, INC.
TABLE 223 CELL BIOLABS, INC: BUSINESS OVERVIEW
TABLE 224 CELL BIOLABS, INC.: PRODUCT OFFERINGS
12.1.14 CREATIVE BIOARRAY
TABLE 225 CREATIVE BIOARRAY: BUSINESS OVERVIEW
12.1.15 MEIJI TECHNO
TABLE 226 MEIJI TECHNO: BUSINESS OVERVIEW
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS
12.2.1 PROMEGA CORPORATION
TABLE 227 PROMEGA CORPORATION: COMPANY OVERVIEW
12.2.2 PERKINELMER
TABLE 228 PERKINELMER: COMPANY OVERVIEW
12.2.3 TECAN TRADING AG
TABLE 229 TECAN TRADING AG: COMPANY OVERVIEW
12.2.4 CARL ZEISS
TABLE 230 CARL ZEISS: COMPANY OVERVIEW
12.2.5 SYSMEX AMERICA, INC.
TABLE 231 SYSMEX AMERICA, INC.: COMPANY OVERVIEW
12.2.6 CELLINK
TABLE 232 CELLINK: COMPANY OVERVIEW
12.2.7 QIAGEN
TABLE 233 QIAGEN: COMPANY OVERVIEW
12.2.8 ILLUMINA, INC.
TABLE 234 ILLUMINA, INC.: COMPANY OVERVIEW
12.2.9 CORNING INCORPORATED
TABLE 235 CORNING INCORPORATED: COMPANY OVERVIEW
12.2.10 10X GENOMICS
TABLE 236 10X GENOMICS: COMPANY OVERVIEW

13 APPENDIX (Page No. – 230)
     13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS


    • 리포트 제목은 자동으로 입력됩니다.
    • *항목은 필수항목입니다.

    의뢰분류*

    성함*

    회사명*

    부서명

    이메일*

    전화번호

    저희 사이트를 알게 된 경로를 가르쳐 주세요.

    문의 내용*

     

    ※개인정보보호정책은여기에서 확인 가능합니다。

    Email 문의도 받고 있습니다.
    아래 주소이며 죄송하지만 "(at)"을 "@"로 바꾸어 보내주시길 부탁드립니다.
    mooneui(at)chosareport-korea.com